Patents by Inventor Ernest Pfadenhauer

Ernest Pfadenhauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200188403
    Abstract: A method of treating exposure to organophosphate agents and preventing morbidity due to such exposure through the administration of a pyrazolopyrimidine compound such as ocinaplon, zaleplon, indiplon, or divaplon.
    Type: Application
    Filed: October 7, 2019
    Publication date: June 18, 2020
    Inventors: David Helton, Ernest Pfadenhauer
  • Patent number: 10478438
    Abstract: A method of treating exposure to organophosphate agents and preventing morbidity due to such exposure through the administration of a pyrazolopyrimidine compound such as ocinaplon, zaleplon, indiplon, or divaplon.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: November 19, 2019
    Inventors: David Reed Helton, Ernest Pfadenhauer
  • Publication number: 20110294823
    Abstract: Tetrahydroindolone and aryl piperazine derivatives for use in treating post-traumatic stress disorder and acute stress disorder.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 1, 2011
    Inventors: David HELTON, David FICK, Ernest PFADENHAUER
  • Publication number: 20090156609
    Abstract: Tetrahydroindolone and aryl piperazine derivatives for use in treating post-traumatic stress disorder and acute stress disorder.
    Type: Application
    Filed: November 10, 2008
    Publication date: June 18, 2009
    Inventors: David Helton, David Fick, Ernest Pfadenhauer
  • Publication number: 20070208030
    Abstract: Compositions comprising tetrahydroindolone derivatives in which the tetrahydroindolone moiety is covalently linked to a substituted arylpiperazine moiety and methods for treating neurological and psychiatric conditions using such compositions are disclosed.
    Type: Application
    Filed: September 27, 2004
    Publication date: September 6, 2007
    Applicant: Abraxis BioScience, Inc.
    Inventors: David Helton, David Fick, Ernest Pfadenhauer, Jason Sharp